Pharmaceuticals News and Research

RSS

Bruker introduces new NMR-based solution for Aloe Vera quality control at Pittcon 2013

Bruker Corporation introduces Assure – Aloe, an NMR-based solution for Aloe Vera quality control. Fully automated, quantitative and qualitative Nuclear Magnetic Resonance (NMR) analysis enables Aloe vera material screening in the cosmetics, natural products and pharmaceutical industries.

From Bruker BioSpin Division 15 Mar 2016

Bruker showcases innovative NMR solutions for pharmaceutical industry at ENC 2015

At the 56th Experimental Nuclear Magnetic Resonance Conference, Bruker this week is show-casing several innovative drug discovery, drug development and process control solutions for small molecule NMR characterization in the pharmaceutical industry.

From Bruker BioSpin Division 15 Mar 2016

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.

15 Mar 2016

Study could lead to potential new therapeutic target with fewer side effects for hypertension

A team of Vermont investigators has been issued a patent for their discovery of a molecule that rescues damaged blood vessels, yet preserves healthy vessels and could serve as a springboard for a new pharmaceutical therapy with fewer side effects for hypertension - a major risk factor for cardiovascular and kidney disease that effects roughly one in three people in the U.S.

15 Mar 2016

Aralez resubmits NDA package for YOSPRALA to FDA

Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, today announced that it has resubmitted to the U.S. Food and Drug Administration the New Drug Application ("NDA") for its investigational candidate, YOSPRALA (PA32540/PA8140) for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.

15 Mar 2016

UCSF study marks important step toward finding cure for Ebola

In experiments carried out partly at the Department of Energy's SLAC National Accelerator Laboratory, scientists have determined in atomic detail how a potential drug molecule fits into and blocks a channel in cell membranes that Ebola and related "filoviruses" need to infect victims' cells.

15 Mar 2016

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

BioSpecifics Technologies Corp., a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum, or CCH, marketed as XIAFLEX in the U.S. and Xiapex in Europe, today announced its financial results for the fourth quarter and full year ended December 31, 2015 and provided a corporate update.

14 Mar 2016

Study: Nearly 29% of cancer survivors suffer financial burden

An analysis of US data from 2011 indicates that nearly 29 percent of cancer survivors are financially burdened as a result of their cancer diagnosis and/or treatment. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also reveals that such hardships can have lasting physical and mental effects on cancer survivors.

14 Mar 2016

Healthful hops compounds could help scientists develop medicines for cancer, inflammatory diseases

Hops, those little cone-shaped buds that give beer its bitter flavor, pack a surprisingly healthful punch. They are widely studied for their ability to halt bacterial growth and disease. Now, researchers report that they are close to synthesizing the healthful hops compounds in the lab. This advance could one day help scientists create medicines from these compounds without having to extract them from plants.

14 Mar 2016

Once-daily nutritional drink can help reduce brain shrinkage in prodromal AD patients

Topline results from the European LipiDiDiet clinical trial were presented today as part of a late-breaking presentation at the Advances in Alzheimer's Therapy congress.

11 Mar 2016

Experts to analyse latest advances in diagnosis, treatment of soft tissue sarcoma at PharmaMar seminar

The creation of a network of centres of reference and adopting measures that promote research and access to treatments are two key aspects for improving the prognosis of patients with soft tissue sarcoma (STS), an uncommon type of cancer that originates in the tissues that connect, support and surround other body structures, such as muscles, fat, blood vessels, nerves, tendons and lining of the joints.

11 Mar 2016

Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab was superior to adalimumab (marketed by AbbVie as HUMIRA) in improving signs and symptoms in patients with active rheumatoid arthritis (RA) at Week 24.

11 Mar 2016

BioLineRx announces year end 2015 financial results, provides operational update

BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for the year ended December 31, 2015.

10 Mar 2016

Merck reports record results for 2015

Merck, a leading science and technology company, reported record results for 2015, emerging stronger from the transformation process that started in 2007. Net sales and EBITDA pre exceptionals were higher than ever before in Merck’s history of nearly 350 years.

From Merck 10 Mar 2016

Scientists discover molecular switch that can burn off excess pounds

The number of overweight people is increasing worldwide -- and thus the risk of developing diabetes or cardiovascular disease.

10 Mar 2016

Secretory capacity of human gut does not decline with age, shows study

A breakthrough in basic research and the first comprehensive study on the secretory activity of the human intestine: over a period of eight years, Dr. Dagmar Krüger of the Department of Human Biology at TU Munich has examined more than 2200 specimens from around 450 patients with bowel disease.

10 Mar 2016

Overprescribing of opioids leads to serious public health problems

Overprescribing of opioids and opioid addiction are serious and growing public health problems in the U.S., and are the focus of a new report by an expert panel, entitled The American Opioid Epidemic: Population Health Implications and Potential Solutions," from the National Stakeholder Panel, Jefferson College of Population Health, which is published in a special supplement to Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The supplement is available open access on the Population Health Managementwebsite

10 Mar 2016

New software takes ensemble approach to determine presence of chemical structure in drug molecule

A computer program that can predict whether or not a given pharmaceutical will have worrying side effects has been developed by researchers in the USA. Md Jamiul Jahid and Jianhua Ruan of the Department of Computer Science, at the University of Texas at San Antonio, have developed the "in silico" testing system for drugs in the early stage of drug development.

9 Mar 2016

New chemometrics package now integrated with Thermo Scientific TruScan RM handheld analyzer

Pharmaceutical manufacturers seeking to conduct their own qualitative and quantitative analyses can now rely on a new chemometrics package that integrates with the Thermo Scientific TruScan RM handheld analyzer.

From Thermo Fisher Scientific Inc. 9 Mar 2016

Thermo Fisher exhibits new UHPLC-MS workflow solutions for biopharmaceutical characterization at Pittcon 2016

Biopharmaceutical companies can now achieve advanced levels of specificity, sensitivity and speed with specialized analytical workflow solutions for the characterization and quantification of proteins.

From Thermo Fisher Scientific Inc. 9 Mar 2016

Pharmaceuticals News and Research

Bruker introduces new NMR-based solution for Aloe Vera quality control at Pittcon 2013

Bruker showcases innovative NMR solutions for pharmaceutical industry at ENC 2015

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Study could lead to potential new therapeutic target with fewer side effects for hypertension

Aralez resubmits NDA package for YOSPRALA to FDA

UCSF study marks important step toward finding cure for Ebola

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

Study: Nearly 29% of cancer survivors suffer financial burden

Healthful hops compounds could help scientists develop medicines for cancer, inflammatory diseases

Once-daily nutritional drink can help reduce brain shrinkage in prodromal AD patients

Experts to analyse latest advances in diagnosis, treatment of soft tissue sarcoma at PharmaMar seminar

Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

BioLineRx announces year end 2015 financial results, provides operational update

Merck reports record results for 2015

Scientists discover molecular switch that can burn off excess pounds

Secretory capacity of human gut does not decline with age, shows study

Overprescribing of opioids leads to serious public health problems

New software takes ensemble approach to determine presence of chemical structure in drug molecule

New chemometrics package now integrated with Thermo Scientific TruScan RM handheld analyzer

Thermo Fisher exhibits new UHPLC-MS workflow solutions for biopharmaceutical characterization at Pittcon 2016

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring